Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications
February 26, 2024 08:30 ET
|
Tenaya Therapeutics, Inc.
Highly selective Small Molecule HDAC6 Inhibitor Effectively Reversed Heart Failure and Improved Diastolic Heart Function Alone or in Combination with SGLT2 Inhibitor in Murine Models of Disease ...
Artificial Intelligence in Cardiology Market Set for Rapid Growth, Forecast 2024-2034: Emphasis on Advanced Diagnostic Solutions with CAGR of 34.14%
January 29, 2024 06:05 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Artificial Intelligence In Cardiology Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. ...
Cardiovascular Perfusion Disposables Market: Rapid Growth Forecast Revealed till 2033
January 24, 2024 01:48 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Perfusion Disposables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ...
Service Credit Union Pledges to Donate $200,000 to First Responders in Campaign With Charlie McAvoy
January 23, 2024 16:53 ET
|
Service Federal Credit Union
Service Credit Union has teamed up with Charlie McAvoy to donate $200,000 toward heart and cancer screenings for first responders.
Pediatric Perfusion Market Poised for Growth, Expected to Surpass USD 829 Million by 2030
December 20, 2023 10:28 ET
|
Research and Markets
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Pediatric Perfusion Market Size, Share & Trends Analysis Report By Product (Pediatric Oxygenators, Pediatric Cannulae, Pediatric Blood Pumps), By...
Global Cardiology IT Workflow Solutions Market Report 2023-2030 - Rise of IT in Healthcare Provides the Foundation for Adoption
November 30, 2023 03:08 ET
|
Research and Markets
Dublin, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The "Cardiology IT Workflow Solutions - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Cardiology IT...
Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare Conference
November 21, 2023 16:30 ET
|
Tenaya Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...
Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
October 26, 2023 08:30 ET
|
Tenaya Therapeutics, Inc.
PKP2 Mutations Are the Leading Cause of ARVC, a Dangerous Condition Linked to Sudden Cardiac Arrest in Young People Estimated to Affect 70,000 People in the US TN-401 Preclinical Studies Demonstrated...
ZyVersa Therapeutics Announces Research Published in the Peer-Reviewed Journal Diabetes Reinforcing IC 100’s Rationale for Inhibiting ASC to Attenuate Damaging Inflammation Associated with Serious Conditions Such as Obesity-related Heart Disease
October 25, 2023 06:50 ET
|
ZyVersa Therapeutics
Obesity exacerbates scarring of the heart through ASC-driven inflammasome activation in the heart leading to damaging inflammation.
Cardiovascular Disease Prevalence Sparks Demand in Global Perfusion Disposables Market - Report Analyzes Market Insights Across 39 Countries with Focus on Valvular Health
October 17, 2023 06:53 ET
|
Research and Markets
Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The "Perfusion Disposables Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures...